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Abstract
Background: Fatigue is a frequent and serious symptom in patients with Multiple Sclerosis (MS). However, to date
there are only few methods for the objective assessment of fatigue. The aim of this study was to develop a
method for the objective assessment of motor fatigue using kinematic gait analysis based on treadmill walking and
an infrared-guided system.
Patients and methods: Fourteen patients with clinically definite MS participated in this study. Fatigue was defined
according to the Fatigue Scale for Motor and Cognition (FSMC). Patients underwent a physical exertion test
involving walking at their pre-determined patient-specific preferred walking speed until they reached complete
exhaustion. Gait was recorded using a video camera, a three line-scanning camera system with 11 infrared sensors.
Step length, width and height, maximum circumduction with the right and left leg, maximum knee flexion angle
of the right and left leg, and trunk sway were measured and compared using paired t-tests (a = 0.005). In addition,
variability in these parameters during one-minute intervals was examined. The fatigue index was defined as the
number of significant mean and SD changes from the beginning to the end of the exertion test relative to the
total number of gait kinematic parameters.
Results: Clearly, for some patients the mean gait parameters were more affected than the variability of their
movements while other patients had smaller differences in mean gait parameters with greater increases in
variability. Finally, for other patients gait changes with physical exertion manifested both in changes in mean gait
parameters and in altered variability. The variability and fatigue indices correlated significantly with the motoric but
not with the cognitive dimension of the FSMC score (R = -0.602 and R = -0.592, respectively; P < 0.026).
Conclusions: Changes in gait patterns following a physical exertion test in patients with MS suffering from motor
fatigue can be measured objectively. These changes in gait patterns can be described using the motor fatigue
index and represent an objective measure to assess motor fatigue in MS patients. The results of this study have
important implications for the assessments and treatment evaluations of fatigue in MS.
Background
Multiple Sclerosis (MS) is a chronic autoimmune disease
of the central nervous system characterized by inflamma-
tion, demyelization and destruction of axons and neurons,
and by gliosis. MS is the most common neurological disor-
der in younger adults with a prevalence of 30-110 per 100,
000 adults [1,2]. In Germany alone, approximately 130,
000 patients suffer from multiple sclerosis [1]. Multiple
sclerosis comprises a variety of symptoms including cen-
tral paresis, spasticity, paraesthesia, ataxia, dysarthria,
visual impairment, cognitive dysfunction and urinary and
bowel dysfunction [3]. However, the most common and
most debilitating symptom [4-6] experienced by 87-92% of
all persons affected by MS is fatigue, recently termed
‘pathological exhaustion’ [7], which is defined as ‘a subjec-
tive lack of physical or mental energy that is perceived by
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daily living’ [8].
The pathophysiology of fatigue in MS is still poorly
understood and the success rates of available treatments
are low. Fatigue is typically exacerbated by exertion and
by heat, where the latter is known as the Uhthoff phe-
nomenon [9]. Use-dependent conduction block has been
proposed as a likely mechanism of fatigue in MS [10]. It
has been suggested that activity results in axonal hyper-
polarization [11] and that conduction blocks may be
induced by depletion of axonal energy supply or by
inflammatory mediators [12,13]. Other changes asso-
ciated with fatigue in MS patients are increased and
extensive cortical activation (including that of non-motor
cortical areas) and reduced cortical inhibition during
simple motor tasks [14,15], and white and grey matter
volume loss [16]. Current management of fatigue in MS
includes physical-based options (such as aerobic exercise,
energy conservation strategies, and psychological and
dietary interventions) [17-19], cooling [20,21], measures
to ameliorate conduction block [22] and the use of other
pharmacological agents [23,24].
The evaluation of treatment efficacy and a patient’s
ability to better perform occupational tasks require a
valid and reliable assessment of fatigue in MS where
patients may suffer from cognitive or from motor fatigue
of from both. Current clinical methods for the assess-
ment of motor fatigue in MS are self-reported instru-
ments for the assessment of subjective fatigue or the
perception that more effort is required to perform a task.
These instruments include the Fatigue Severity Scale
(FSS) [25], the Fatigue Impact Scale (FIS) [26], the Fati-
gue Descriptive Scale (FDS) [27], and a Visual Analogue
Scale (VAS) [28]. While most of these instruments have
adequate validity and reliability [26,28,29], they all rely
on subjective reporting and are unable to differentiate
between inability and reluctance to generate or maintain
the required force. While recent technological develop-
ments [30] are promising for measuring fatigue objec-
tively, they do not provide information on patient
function.
Clinically, motor fatigue can be defined as a reduction
in maximal walking distance that cannot be explained by
the degree of paresis, ataxia or spasticity. Many patients
with motor fatigue demonstrate a gait pattern that is
initially close to normal, although angular exertions may
be statistically smaller [31], but distinctly different from
normal when they are exhausted. Patients are generally
able to clearly describe the changes in their gait pattern,
such as, for instance, one of their feet starting to drop,
one leg being dragged or becoming unsteady. Hence,
recording patients’ perception of their function or change
in function provides critical information for assessing a
patient’s status. Interestingly, the maximum walking dis-
tance to exhaustion on a treadmill at standardized condi-
tions without prior exertion and after a full night’sr e s t
appears to be constant for each individual [32] suggesting
a physical cause for their perceived exhaustion. Conse-
quently, it is possible that abnormalities will only mani-
fest in a neurological exam following physical exhaustion.
Hence, objective assessment of these functional altera-
tions during an exertion test may provide insight into
underlying neurological changes associated with MS and
form the foundation for determining limitations of a
patient’s working capacity that may warrant additional or
alternative treatment or early retirement.
The purpose of this study was to develop an objective
tool for the assessment of motor fatigue in MS, the fati-
gue index. It was hypothesized that specific gait para-
meters including step length, width and height, bilateral
circumduction, bilateral knee flexion angle and medio-
l a t e r a ls w a yc h a n g ed u r i n gt he exertion test, and that
t h ev a r i a b i l i t yo ft h es t e pc y c l ei sd i f f e r e n ta f t e rc o m -
pared to prior to the exertion test.
Methods
From March to April 2009, fourteen patients with defi-
nite MS were screened in a neurological rehabilitation
clinic for complaints about motor fatigue and having a
limited maximal walking distance. The study was
approved by the Institutional Review Board and was con-
ducted in accordance with the Declaration of Helsinki.
The duration of one data collection session was one hour.
Subjects
Fourteen patients participated in this study after giving
informed consent (nine females and five males; age: 42 ±
7.6 years; height: 1.71 ± 0.09 m; mass: 76.1 ± 19.2 kg).
Patients’ impairment ranged from minimal to moderate
signs of impairment (Expanded Disability Status Scale
(EDSS): 3.6 ± 1.33; range: 1.0-5.5). Time since onset of
symptoms was 7.5 ± 5.7 years and time since diagnosis
5.0 ± 4.4 years. Maximal walking distance until exhaustion
was 362 ± 439 m (63-1524 m).
Fatigue questionnaire
Fatigue was rated using the self-administered Fatigue Scale
for Motor and Cognition (FSMC). The scale was recently
developed and evaluated [33] and found to be sufficiently
sensitive to discriminate between motor and cognitive fati-
gue. Ten questions relate to motor fatigue and ten to cog-
nitive fatigue. Scores between 22 and 26 points indicate
light motor fatigue, scores between 27 and 31 points indi-
cate moderate fatigue, and scores of 32 points or higher
indicate severe fatigue. Corresponding ranges for cognitive
fatigue are 22-27, 28-33 and ≥34 points.
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Each patient participated in a physical exertion test on a
treadmill. For this test, patients walked on a treadmill
until they experienced complete exhaustion. Patients
were wearing a safety harness to prevent falling. The
speed of the treadmill was set to a subject-specific com-
fortable walking speed and kept constant throughout
the test. During the test, patients were repeatedly asked
to rate their physical exhaustion on a scale from 1 (not
exhausted at all) to 10 (unable to continue the test).
The physical exertion test was stopped one minute after
the patient seriously requested to stop or to rest (com-
pletely exhausted; mean exhaustion score: 6.1 ± 2.4).
Gait recording
Gait data was recorded using the wireless AS200 system
(80 Hz; LUKOtronic, Lutz Mechatronic Technology e.U.,
Innsbruck, Austria) consisting of a three line-scanning
camera system and 11 active infrared markers with a 2-
mm accuracy. The markers are connected by cable to a
unit worn on a belt. The camera unit was positioned pos-
terior of the patient behind the treadmill (Figure 1). The
system was synchronized with a standard video camera
(Digital Ixus 65, Canon Inc., Tokyo, Japan). Eleven active
infrared markers were attached to the patient’s body:
bilaterally on the shoes on top of the calcaneus; bilater-
ally on the Achilles tendon at the level of the ankle; bilat-
erally on the posterior aspect of the knee; bilaterally on
the belt at the highest point of the ilium; on the spine at
the level of the sternum; bilaterally centered on Margo
medialis.
After a patient reached comfortable walking speed, three
dimensional marker data and video images were recorded
for one minute at the beginning of the test (t1)a n df o ro n e
minute when patients stated that they could no longer
walk and were completely exhausted (t2). Following this
statement, the patient had to walk for one more minute,
and data for this minute was recorded (t2). The current
physical exhaustion at each of the recordings was charted
on the physical exhaustion scale (see above) before and
Figure 1 Test set-up. Patients wore safety harness during all tests to prevent injury by potential falls. The infrared camera system and the video
camera were positioned posterior of the patient behind the treadmill. The acquisition computer was operated by one tester and placed behind
the cameras to allow for visual observation of all tests.
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one hour per subject.
Pathological diagnostic criteria (gait abnormalities)
Step length, step width, step height, maximum circum-
duction with the right and left leg, maximum knee flex-
ion angle of the right and left leg, and medio-lateral sway
of the upper body were calculated for each step using the
three-dimensional coordinates of the infrared markers.
Mean and standard deviations for each parameter and
time interval were calculated for each patient and used
for further analysis. Significant changes in the mean and
standard deviations of these parameters were used as
probable indicators of fatigue. It was assumed that a
patient’s gait pattern at the rested state corresponds to
their “normal” gait pattern. Therefore, the changes in gait
parameters after physical exertion can be regarded as
pathological, although the direction of changes was irre-
levant. The fatigue index comprised components of mean
gait changes and changes in variability and was defined as
indexfatigue =
1
2
·

indexmean + indexvariability

=
1
2
·

Nsigniﬁcant mean changes
Ngait parameters
+
Nsigiﬁcant SD changes
Ngait parameters

where Nsignificant_mean_changes was the number of para-
meters that had a significant mean change from t1 to t2,
Nsignificant_SD_changes was the number of parameters that
had a significant SD change from t1 to t2 and Ngait_para-
meters was the number of gait parameters. Step length, step
width, step height are global (non-side-specific) measures,
and differences in these parameters can originate from dif-
ferences in the left leg, right leg or both legs. Hence, these
global gait parameters were weighted with a factor 2 and
the side-specific parameters right and left circumduction
and right and left knee flexion angle were weighted with a
factor 1. Possible values for the fatigue, mean index and
variability indices are between 0 and 1, respectively.
Statistical Analysis
All statistical tests were performed using StatFree Ver-
sion 4.4.2.2 (VietenDynamics) and Stata Version 10.1
(StatCorp LP, College Station, Texas, USA). Descriptive
analyses of numerical parameters included mean, median,
minimum and maximum, and distribution and standard
deviation. All parameters were tested for normal distribu-
tion. Differences in normally distributed parameters
between t1 and t2 were detected using Student’st - t e s t s
for paired samples. Differences in non-normally distribu-
ted parameters between t1 and t2 were detected using
Wilcoxon signed-rank tests. Differences in parameter
variability between t1 and t2 were detected using the stan-
dard deviation test (SD test). Bonferroni adjustment was
applied to account for multiple comparisons, and the sig-
nificance level for all statistical tests was set a priori to a
= 0.005. Bivariate Pearson correlation coefficients were
used to detect significant associations between the com-
ponents of the fatigue index, the dimensions of FSMC
and the distance walked during the physical exertion test
(a = 0.05).
Results
The fatigue index for this patient group ranged from
0.33-0.92, the mean index ranged from 0.00-0.92 and
the variability index ranged from 0.25-0.92 (Table 1).
Clearly, for some patients the mean gait parameters
were more affected than the variability of their move-
ments while other patients had smaller differences in
mean gait parameters with greater changes in variability.
Finally, for other patients gait changes with physical
exertion manifested in both changes in mean gait para-
meters and in altered variability. For instance, one
patient (patient 9) showed relatively regular patterns of
circumduction with their right leg at the beginning of
the physical exertion test with a shift in circumduction
to smaller values and more variable wave patterns at the
end of the physical exertion test (Figure 2). Another
patient (patient 5) showed similar mean values for their
knee flexion angles during one minute but had clear
irregularities in their pattern manifesting as more irregu-
lar knee extension movements and additional irregulari-
ties close to full knee extension (Figure 3).
The gait parameters that showed significant differences
with fatigue for most patients were step length, width and
height (Figure 4) followed by knee flexion angle (Figure 5)
and circumduction (Figure 6). The gait parameter that
Table 1 Fatigue index with sub-indices mean and
variability for all patients
Patient ID Indexmean Indexvariability Indexfatigue
1 0.00 0.67 0.33
2 0.83 0.67 0.75
3 0.75 0.58 0.67
4 0.42 0.42 0.42
5 0.58 0.58 0.58
6 0.42 0.25 0.33
7 0.67 0.42 0.54
8 0.58 0.67 0.63
9 0.58 0.50 0.54
10 0.67 0.50 0.58
11 0.75 0.33 0.54
12 0.92 0.92 0.92
13 0.58 0.33 0.46
14 0.50 0.58 0.54
Mean 0.59 0.53 0.56
SD 0.22 0.17 0.16
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number of subjects was trunk sway (Figure 7).
The variability index and the fatigue index correlated
significantly with the overall FSMC and with the
motoric dimension of the FSMC, respectively (Table 2).
In contrast, the mean index did not correlate signifi-
cantly with any of the FSMC dimensions. While the
fatigue index correlated with both the mean index and
Figure 2 Circumduction of the right leg in a 15-sec interval during the first (top graph) and last (bottom graph) minute of the
physical exertion test for patient 9.
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index did not correlate significantly. None of the com-
ponents of the fatigue index correlated with the dis-
tance walked during the physical exertion test. All
dimensions of the FSMC correlated significantly with
each other. The mean overall, cognitive and motoric
FSMC scores were 64.3 ± 19.3, 26.6 ± 12.3 and 37.7 ±
8.3 points, respectively (indicating severe global fatigue,
light cognitive fatigue and severe motor fatigue,
respectively).
Figure 3 Knee flexion angle in a 15-sec interval during the first (top graph) and last (bottom graph) minute of the physical exertion
test for patient 5.A –additional variability during knee extension; B–additional variability close to full knee extension.
Sehle et al. Journal of NeuroEngineering and Rehabilitation 2011, 8:59
http://www.jneuroengrehab.com/content/8/1/59
Page 6 of 13Overall, seven of the eight gait parameters changed
significantly between t1 and t2 for this group of patients
(p < 0.001; Table 3). When fatigued, patients walked on
average with longer step lengths, smaller circumduction
with their right leg, greater circumduction with their left
leg, flexed their knees more and swayed their upper
Figure 4 Mean (1SD) step length, width and height for each patient during one minute of treadmill walking at the beginning and at
the end of the physical exertion test, respectively. * indicates significant differences between mean values at the beginning and end of the
test; † indicates significant differences between the standard deviations at the beginning and end of the test (P < 0.005).
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revealed that the variability of steps between t1 and t2
increased for seven gait parameters with increasing
exhaustion of the patients (p < 0.003; Table 1). Follow-
ing exertion, the variability of the significant gait para-
meters increased by 9-121% compared to prior to
exertion. On average, the mean index and the variability
index showed comparable values (Table 1).
Discussion
According to guidelines proposed by the MS Council
for Clinical Practice Guidelines in 1998, fatigue is
Figure 5 Mean (1SD) peak knee flexion angle for the right and left leg for each patient during one minute of treadmill walking at
the beginning and at the end of the physical exertion test, respectively. * indicates significant differences between mean values at
the beginning and end of the test; † indicates significant differences between the standard deviations at the beginning and end of the test
(P < 0. 005).
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energy that is perceived by the individual or caregivers
to interfere with usual and desired activities” [34].
Within this definition, the term subjective implies that
fatigue is not measurable, may be psychogenic or not
even exist. However, the results of this study clearly
showed–despite pre-determined constant walking
speed–(a) that fatigue in MS patients manifests as
c h a n g e si ng a i tp a t t e r n sa n d( b )t h a ts o m ec h a n g e si n
gait patterns associated with fatigue are consistent
across a group of patients suffering from MS. Hence,
the results of this study provide evidence for the exis-
tence of motor fatigue and suggest that motor fatigue
is a pathophysiological phenomenon.
Figure 6 Mean (1SD) circumduction for the right and left leg for each patient during one minute of treadmill walking at
the beginning and at the end of the physical exertion test, respectively. * indicates significant differences between mean values at
the beginning and end of the test; † indicates significant differences between the standard deviations at the beginning and end of the test
(P < 0. 005).
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its subcategories mean index and variability index and
the lack of statistical significant correlations between
these two subcategories suggest that both the mean and
variability index described two different phenomena.
Hence, both subcategories are important measures for
motor fatigue in MS. In addition, the significant correla-
tion of the variability and fatigue indices with the moto-
ric dimension of the FSMC but not with its cognitive
dimension supports the specificity of the fatigue index
for the motoric aspect of fatigue in multiple sclerosis.
Interestingly, the fatigue index correlated negatively with
the FSMC. The FSMC is a self-administered question-
naire, and data obtained with the FSMC may be distorted
by overestimation because of a deficient self-awareness or
underestimation because of depression. Depression is a
well-known confounding factor of the FSMC [33]. This
discrepancy highlights the urgent need for an objective
marker of fatigue. In addition, while the FSMC measures
the overall subjective status of a patient, the fatigue index
describes the extent to which a patient’s gait changes with
fatigue. The results of this study suggest that gait patterns
of patients with a poor overall subjective status will be
affected less by fatigue than those of patients with a better
overall subjective status. It is possible that gait patterns in
patients with a poor overall subjective status are already
compromised at the beginning of the fatigue test. This
result suggests that comparing general gait patterns in MS
patients to those of age-matched healthy subjects may pro-
vide additional objective information about a patient’s
functional status.
Individual results showed changes in variability of
movement patterns with fatigue. Greater variability dur-
ing knee extension and close to full extension in one
patient (Figure 2) suggests disrupted motor coordination,
which may be caused by additional activity of the antago-
nists or by insufficient force production by the agonists.
For instance, patients with MS use excessive forces for
daily tasks such as lifting and placing an object [35].
Thus, it is feasible that using excessive muscle force dur-
ing daily activities such as walking may result in addi-
tional fatigue that manifests as increased variability of
movement patterns.
Multiple reasons may be responsible for the changes in
gait patterns observed with fatigue in MS patients.
Patients in this study presented with slightly increased
step length at the end of the physical exertion test,
which–from a clinical perspective–is not typical for
motor fatigue in MS patients. However, this change
c o u l db ee x p l a i n e db yt h ep r e s e n c eo fm u s c l ef a t i g u e .
Granacher et al. [36] previously showed that muscle fati-
gue generated by isokinetic contraction resulted in
greater stride length in older healthy subjects while
Figure 7 Mean (1SD) medio-lateral trunk sway for each patient
during one minute of treadmill walking at the beginning and at
the end of the physical exertion test, respectively. * indicates
significant differences between mean values at the beginning and
end of the test; † indicates significant differences between the
standard deviations at the beginning and end of the test (P < 0. 005).
Table 2 Cross-correlations (Pearson’s correlation coefficient, P-value) between dimensions of the fatigue index,
dimensions of the Fatigue Scale for Motor and Cognition (FSMC) and distance walked during the physical exertion
test
R
P-value
indexmean indexvariability indexfatigue FSMCoverall FSMCcognitive FSMCmotoric distance walked
indexmean 1
indexvariability 0.209
0.473
1
indexfatigue 0.835
< 0.001
0.713
0.004
1
FSMCoverall -0.209
0.473
-0.560
0.037
-0.465
0.094
1
FSMCcognitive -0.092
0.753
-0.473
0.087
-0.331
0.248
0.958
< 0.001
1
FSMCmotoric -0.350
0.220
-0.602
0.023
-0.592
0.026
0.906
< 0.001
0.747
0.002
1
distance walked 0.366
0.198
0.277
0.338
0.421
0.134
-0.535
0.049
-0.461
0.097
-0.562
0.037
1
Significant correlations (P < 0.05) are shown in bold font.
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Hence, it is possible that patients with MS suffer from an
earlier on-set and faster rate of muscle fatigue compared
to healthy control subjects. In addition, MS patients with
greater fatigue have reduced isometric strength in the
quadriceps muscle [37], which may represent compro-
mised capacity to produce sufficiently large muscle
moments about the joints of the lower extremities during
walking.
Interestingly, functional imaging studies have reported
increasing evidence that patients with MS experience
greater cerebral activity during performance of motor
and cognitive tests compared to normal volunteers
[38,39]. Similar observations have been made in patients
after manifestation of their first clinical symptom (clini-
cally isolated syndrome, CIS) [40,41] and in patients
without neurological deficits at the time of the functional
imaging [42]. In addition, patients with a benign course
of MS have shown increased cerebral activity [43] which
may represent some form of compensation. In the late
phase of MS (and with increasing fatigue) this mechan-
ism of compensation is exhausted and compensatory cer-
ebral activity is decreased [44,45]. However, while only
few investigations have investigated a direct relationship
between fatigue and functional imaging [15], stimulation
studies have found that impaired central motor activation
is involved in MS-fatigue [37]. Other studies [46]
reported an increased central activation during fatiguing
exercises probably reflecting an additional compensatory
central activation. Thus, observed deterioration of gait
parameters in exhausted patients could also reflect a
breakdown of these compensatory mechanisms. In addi-
tion, the fact that patients with a progressive disorder
such as multiple sclerosis show only small improvements
in motor-evoked potential and maximum voluntary con-
traction using functional electrical stimulation [47] sug-
gests compromised plasticity of their motor cortex and
that their impaired motor activation is presumably asso-
ciated with diminished muscle coordination. Hence, the
gait changes observed following the physical exertion test
in MS patients may stem from the combination of
reduced muscle strength and diminishing coordination
reflected in greater variability in movement patterns.
Individual gait changes with fatigue in MS patients are
expected to be asymmetric, that is affecting either the
left or the right side more, because typically dissemi-
nated regions are involved. Indeed, gait compensation
with fatigue in this study population was asymmetric.
However, the sidedness of these effects, that is circum-
duction with their right leg decreased substantially while
circumduction with their left leg increased considerably,
presumably occurred by chance. It can be assumed that
in a larger study, differences in gait patterns with fatigue
in MS patients would be asymmetric but not side-speci-
fic. In addition, it is possible that different symptomatol-
ogy, such as spastic syndromes or ataxic disturbances,
may be reflected in different changes in gait patterns.
Gait patterns of MS patients differ from those of
healthy persons [31]. Kelleher et al. [31] reported reduced
gait speed, reduced maximum hip and knee extension,
ankle plantarflexion angle and propulsive force for MS
patients compared to healthy persons and that these
Table 3 Results of the t-Test and SD-Test comparing eight gait parameters between t1 and t2 (N = 14)
Gait parameters Mean (t1) Mean (t2) Significance
t-Test
Std. Dev. (t1) Std. Dev. (t2) Significance
SD-Test
Step width [cm] 15.3 15.5 0.032 3.9 4.4 < 0.001
Step height [cm] 10.1 9.8 n.s. 4.7 5.1 0.002
Step length [cm] 23.6 24.3 0.005 7.4 6.9 n.s.
Circumduction right leg [cm] 6.8 1.6 < 0.001 4.7 10.4 < 0.001
Circumduction left leg [cm] 1.6 5.5 < 0.001 4.9 10.4 < 0.001
Knee flexion angle right leg [°] 12.8 20.5 < 0.001 6.4 11.7 < 0.001
Knee flexion angle left leg [°] 12.7 17.8 < 0.001 7.9 10.8 < 0.001
Sway [cm] 3.4 3.9 < 0.001 5.4 6.0 < 0.001
n.s.–not significant at a = 0.05
Table 4 Differential diagnosis of fatigue or causes of secondary weakness/tiredness in MS
MS related causes for lack of energy Non-MS related causes for lack of energy
Depression Depression
Nocturia Thyroid function
Sleep disturbance Anemia
Spasticity, paresis, uneconomic movement Infection (bladder)
Lack of condition Electrolytes
Side effects of medication (Liuresal, benzodiazepine etc.)
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patients. Hence, the results of Kelleher et al. and those of
this study suggest that fatigue in MS patients appears to
amplify changes in gait patterns already present because
of the disease. While the study sample in this study was
rather small, it is possible that in the general MS popula-
tion the extent of gait changes with fatigue is associated
with the severity of symptoms. For instance, patients
with greater perceived walking limitations have less
movement counts from an accelerometer compared to
patients with smaller walking limitations [48]. In addi-
tion, the results of this study showed that gait patterns
generally become more variable or clumsier with fatigue.
Such changes in gait patterns may generate other pro-
blems such as perception of instability or increased risk
of falling. Thus, the changes in gait patterns observed in
fatigued MS patients likely affect a patient’sc o m p l e t i o n
of daily activities.
Therefore, assessing changes in gait patterns using a
physical exertion test and the fatigue index may be useful
for the objective assessment of functional limitations
associated with fatigue in MS patients and for evaluating
rehabilitation programs aimed at improving patient func-
tion and reducing fatigue. However, the maximum dis-
tance walked during the exertion test should also be
considered in the evaluation of such interventions. In
addition, such an objective tool may be useful for differ-
entiating between MS related motor fatigue and condi-
tions that are unrelated to MS but may cause lack of
energy (Table 4). Interestingly, only few subjects showed
differences in trunk sway with fatigue, and hence the
inclusion of this parameter in the fatigue index should be
reconsidered. However, it is possible that trunk sway was
restricted by the use of the safety harness in this group of
patients. The influence of these factors should be exam-
ined in future studies. While obtaining gait data is more
time-consuming than conventional assessment tools (i.e.
questionnaires [26,27,29,33]) and requires specialized
technical equipment, the information gained in this study
is objective–and hence not affected by a patient’sc o n -
torted self-awareness–and reliable. The latter is the pre-
requisite for obtaining meaningful data on a patient’s
physical status and may be particularly valuable for asses-
sing a patient’s ability to perform occupational tasks and
consequently for determining a patient’s entitlement for
early retirement because of their disease. Comparing gait
patterns in MS patients with and without fatigue and in
healthy volunteers would allow for elucidation of the dif-
ferent dimensions, particularities and special features in
gait patterns of fatigue in MS patients.
Conclusions
Distinct changes in gait patterns of MS patients were
recorded through two identical tests before and
following physical exertion. These changes in gait pat-
terns can be expressed by the motor fatigue index and
represent an objective measure to assess motor fatigue
in MS patients. Assessing gait changes during a physical
exertion test appears to be a useful experimental
method for investigating different dimensions and
pathomechanisms of fatigue in MS. In addition, an
objective tool for assessing motor fatigue in MS is useful
for a more precise diagnosis of motor fatigue in MS, for
the design and evaluation of treatment and rehabilita-
tion programs aimed at improving symptoms and for
evaluating a patient’s ability to perform occupational
tasks.
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